Published in Am J Public Health on August 01, 1987
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health (1995) 1.36
Odd man out: a graphical approach to meta-analysis. Am J Public Health (1988) 1.11
The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study. BMJ (2001) 1.03
Infant mortality rates regressed against number of vaccine doses routinely given: is there a biochemical or synergistic toxicity? Hum Exp Toxicol (2011) 0.87
Immunisation and the sudden infant death syndrome. New Zealand Cot Death Study Group. Arch Dis Child (1995) 0.87
Sudden unexpected deaths and vaccinations during the first two years of life in Italy: a case series study. PLoS One (2011) 0.77
DTP and SIDS: when data differ. Am J Public Health (1987) 0.75
Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) (1981) 8.48
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Evolution of epidemiology of sudden infant death syndrome. Epidemiol Rev (1980) 3.54
Severity of notified whooping cough. Br Med J (1976) 3.24
Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs. JAMA (1984) 1.59
Possible temporal association between diphtheria-tetanus toxoid-pertussis vaccination and sudden infant death syndrome. Pediatr Infect Dis (1983) 1.23
Diphtheria-tetanus toxoids-pertussis vaccination and sudden infant deaths in Tennessee. J Pediatr (1982) 1.16
Immunization and cot deaths. Lancet (1982) 1.08
Estimated effects of a delay in the recommended vaccination schedule for diphtheria and tetanus toxoids and pertussis vaccine. JAMA (1987) 0.90
Infection and immunization. Scott Med J (1979) 0.86
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40
Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med (1988) 6.36
Histamine-2 receptor antagonists and gastric cancer. Epidemiology (1996) 5.43
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ (2001) 5.40
Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA (1999) 5.37
Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med (2000) 5.37
Confounding by indication. Epidemiology (1996) 5.01
Reviews of evidence regarding interventions to reduce alcohol-impaired driving. Am J Prev Med (2001) 4.99
Antidepressants and suicide. BMJ (1995) 4.84
Concepts of interaction. Am J Epidemiol (1980) 4.80
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA (1989) 4.52
Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39
Reporting the results of epidemiologic studies. Am J Public Health (1986) 4.14
Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient. Gastroenterology (1976) 4.08
Outbreak of tick-borne relapsing fever in Spokane County, Washington. JAMA (1969) 4.00
Effectiveness of bicycle safety helmets in preventing head injuries. A case-control study. JAMA (1996) 3.97
Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med (2001) 3.92
HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91
Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum (1995) 3.89
Epidemiology and the internet. Epidemiology (1997) 3.48
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet (2001) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
Epidemic Shiga bacillus dysentery in Central America. I. Etiologic investigations in Guatemala, 1969. J Infect Dis (1970) 3.41
Oral contraceptives and neuro-ophthalmologic interest. Arch Ophthalmol (1965) 3.35
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet (2000) 3.35
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med (1995) 3.29
Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. N Engl J Med (1993) 3.27
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
Comprehensive drug surveillance. JAMA (1970) 2.92
Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology (1999) 2.69
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
Bicycle helmets: it's time to use them. BMJ (2000) 2.62
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology (1992) 2.48
Drugs--remarkably nontoxic. N Engl J Med (1974) 2.43
Symposium on pathology of the gastrointestinal tract-Part II. Small intestinal biopsy. Hum Pathol (1975) 2.40
Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Low power and striking results--a surprise but not a paradox. N Engl J Med (1995) 2.37
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
The discovery of drug-induced illness. N Engl J Med (1977) 2.29
Reviews of evidence regarding interventions to increase the use of safety belts. Am J Prev Med (2001) 2.28
Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25
The Seattle children's bicycle helmet campaign: changes in helmet use and head injury admissions. Pediatrics (1994) 2.23
The association between the purchase of a handgun and homicide or suicide. Am J Public Health (1997) 2.19
Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18
The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol (1989) 2.12
Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA (1999) 2.09
The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum (1994) 2.06
Effectiveness of bicycle safety helmets in preventing serious facial injury. JAMA (1996) 2.05
Fenoterol and fatal asthma. Lancet (1990) 2.05
Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Ann Intern Med (1970) 2.04
Epidemiology of bicycle injuries and risk factors for serious injury. Inj Prev (1997) 2.04
Reviews of evidence regarding interventions to increase use of child safety seats. Am J Prev Med (2001) 2.03
Incidence of bicycle-related injuries in a defined population. Am J Public Health (1990) 2.03
Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1977) 2.00
Omeprazole, other antiulcer drugs and newly diagnosed gout. Br J Clin Pharmacol (1997) 1.99
The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med (1992) 1.98
Risk of injury to children less than 5 years of age in day care versus home care settings. Pediatrics (1989) 1.90
Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum (2000) 1.89
Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol (1978) 1.88
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med (2001) 1.84
Antidepressant drugs and suicide. J Clin Psychopharmacol (1992) 1.80
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med (1994) 1.79
Risk factors for postherpetic neuralgia. Arch Intern Med (1997) 1.79
MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team. Pediatrics (1997) 1.77
Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology (1995) 1.76
A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol (1987) 1.75
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis (2000) 1.75
The epidemic of endometrial cancer: a commentary. Am J Public Health (1980) 1.74
Vaginal spermicides and congenital disorders. JAMA (1981) 1.74
Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study. Circulation (1998) 1.74
The role of non-steroidal anti-inflammatory drugs in acute liver injury. BMJ (1992) 1.72
Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst (1997) 1.68
Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol (1998) 1.66
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
Verotoxin producing Escherichia coli O 157 infections associated with the consumption of yoghurt. Epidemiol Infect (1993) 1.65
Fatal drug reactions among medical inpatients. JAMA (1971) 1.64
The demand for eating disorder care. An epidemiological study using the general practice research database. Br J Psychiatry (1996) 1.63
Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative. Cancer (1990) 1.63
The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception (1999) 1.62
Pregnancies and terminations after 1995 warning about third-generation oral contraceptives. Lancet (1998) 1.61
Population-based study of unintentional injury incidence and impact during childhood. Am J Public Health (1989) 1.61
Evaluation of drug efficacy by a preference technic. N Engl J Med (1966) 1.60
Injuries involving off-road cycling. J Fam Pract (1997) 1.60
Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med (1987) 1.59
Haemophilus influenzae vaccine. Br J Gen Pract (1995) 1.59
Risk compensation theory should be subject to systematic reviews of the scientific evidence. Inj Prev (2001) 1.57